195 related articles for article (PubMed ID: 26244761)
1. Novel Histone Deacetylase Class IIa Selective Substrate Radiotracers for PET Imaging of Epigenetic Regulation in the Brain.
Bonomi R; Mukhopadhyay U; Shavrin A; Yeh HH; Majhi A; Dewage SW; Najjar A; Lu X; Cisneros GA; Tong WP; Alauddin MM; Liu RS; Mangner TJ; Turkman N; Gelovani JG
PLoS One; 2015; 10(8):e0133512. PubMed ID: 26244761
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Class IIa Histone Deacetylases Expression and In Vivo Epigenetic Imaging in a Transgenic Mouse Model of Alzheimer's Disease.
Chen YA; Lu CH; Ke CC; Chiu SJ; Chang CW; Yang BH; Gelovani JG; Liu RS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445342
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging HDACs class IIa expression-activity and pharmacologic inhibition in intracerebral glioma models in rats using PET/CT/(MRI) with [
Laws MT; Bonomi RE; Kamal S; Gelovani DJ; Llaniguez J; Potukutchi S; Lu X; Mangner T; Gelovani JG
Sci Rep; 2019 Mar; 9(1):3595. PubMed ID: 30837601
[TBL] [Abstract][Full Text] [Related]
4. High-Contrast PET Imaging with [
Turkman N; Xu S; Huang CH; Eyermann C; Salino J; Khan P
J Med Chem; 2023 Apr; 66(8):5611-5621. PubMed ID: 37068265
[TBL] [Abstract][Full Text] [Related]
5. Imaging epigenetic regulation by histone deacetylases in the brain using PET/MRI with ¹⁸F-FAHA.
Yeh HH; Tian M; Hinz R; Young D; Shavrin A; Mukhapadhyay U; Flores LG; Balatoni J; Soghomonyan S; Jeong HJ; Pal A; Uthamanthil R; Jackson JN; Nishii R; Mizuma H; Onoe H; Kagawa S; Higashi T; Fukumitsu N; Alauddin M; Tong W; Herholz K; Gelovani JG
Neuroimage; 2013 Jan; 64():630-9. PubMed ID: 22995777
[TBL] [Abstract][Full Text] [Related]
6.
Fukumitsu N; Yeh SH; Flores Ii LG; Mukhopadhyay U; Young D; Ogawa K; Jeong HJ; Tong W; Gelovani JG
Contrast Media Mol Imaging; 2018; 2018():3612027. PubMed ID: 29755299
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brain.
Reid AE; Hooker J; Shumay E; Logan J; Shea C; Kim SW; Collins S; Xu Y; Volkow N; Fowler JS
Nucl Med Biol; 2009 Apr; 36(3):247-58. PubMed ID: 19324270
[TBL] [Abstract][Full Text] [Related]
8. Low- and high-cocaine intake affects the spatial and temporal dynamics of class IIa HDAC expression-activity in the nucleus accumbens and hippocampus of male rats as measured by [18F]TFAHA PET/CT neuroimaging.
Perrine SA; Alsharif WF; Harutyunyan A; Kamal S; Viola NT; Gelovani JG
Addict Neurosci; 2022 Dec; 4():. PubMed ID: 36540409
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide labeling and evaluation of candidate radioligands for PET imaging of histone deacetylase in the brain.
Seo YJ; Muench L; Reid A; Chen J; Kang Y; Hooker JM; Volkow ND; Fowler JS; Kim SW
Bioorg Med Chem Lett; 2013 Dec; 23(24):6700-5. PubMed ID: 24210501
[TBL] [Abstract][Full Text] [Related]
10. Spatial and temporal dynamics of HDACs class IIa following mild traumatic brain injury in adult rats.
Kamal SR; Potukutchi S; Gelovani DJ; Bonomi RE; Kallakuri S; Cavanaugh JM; Mangner T; Conti A; Liu RS; Pasqualini R; Arap W; Sidman RL; Perrine SA; Gelovani JG
Mol Psychiatry; 2022 Mar; 27(3):1683-1693. PubMed ID: 35027678
[TBL] [Abstract][Full Text] [Related]
11. PET imaging demonstrates histone deacetylase target engagement and clarifies brain penetrance of known and novel small molecule inhibitors in rat.
Schroeder FA; Wang C; Van de Bittner GC; Neelamegam R; Takakura WR; Karunakaran A; Wey HY; Reis SA; Gale J; Zhang YL; Holson EB; Haggarty SJ; Hooker JM
ACS Chem Neurosci; 2014 Oct; 5(10):1055-62. PubMed ID: 25188794
[TBL] [Abstract][Full Text] [Related]
12. Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach.
Hsu KC; Liu CY; Lin TE; Hsieh JH; Sung TY; Tseng HJ; Yang JM; Huang WJ
Sci Rep; 2017 Jun; 7(1):3228. PubMed ID: 28607401
[TBL] [Abstract][Full Text] [Related]
13. The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
Zeglis BM; Pillarsetty N; Divilov V; Blasberg RA; Lewis JS
Nucl Med Biol; 2011 Jul; 38(5):683-96. PubMed ID: 21718944
[TBL] [Abstract][Full Text] [Related]
14. Advances in the Development of PET Ligands Targeting Histone Deacetylases for the Assessment of Neurodegenerative Diseases.
Tago T; Toyohara J
Molecules; 2018 Jan; 23(2):. PubMed ID: 29385079
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biochemical evaluation, radiolabeling and in vivo imaging with high affinity class-IIa histone deacetylase inhibitor for molecular imaging and targeted therapy.
Turkman N; Liu D; Pirola I
Eur J Med Chem; 2022 Jan; 228():114011. PubMed ID: 34875522
[TBL] [Abstract][Full Text] [Related]
16. Targeting Class IIa HDACs: Insights from Phenotypes and Inhibitors.
Liu L; Dong L; Bourguet E; Fairlie DP
Curr Med Chem; 2021; 28(42):8628-8672. PubMed ID: 34212828
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in class IIa histone deacetylases research.
Asfaha Y; Schrenk C; Alves Avelar LA; Hamacher A; Pflieger M; Kassack MU; Kurz T
Bioorg Med Chem; 2019 Nov; 27(22):115087. PubMed ID: 31561937
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor.
Luckhurst CA; Aziz O; Beaumont V; Bürli RW; Breccia P; Maillard MC; Haughan AF; Lamers M; Leonard P; Matthews KL; Raphy G; Stott AJ; Munoz-Sanjuan I; Thomas B; Wall M; Wishart G; Yates D; Dominguez C
Bioorg Med Chem Lett; 2019 Jan; 29(1):83-88. PubMed ID: 30463802
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases.
Lahm A; Paolini C; Pallaoro M; Nardi MC; Jones P; Neddermann P; Sambucini S; Bottomley MJ; Lo Surdo P; Carfí A; Koch U; De Francesco R; Steinkühler C; Gallinari P
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17335-40. PubMed ID: 17956988
[TBL] [Abstract][Full Text] [Related]
20. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.
Lemon DD; Horn TR; Cavasin MA; Jeong MY; Haubold KW; Long CS; Irwin DC; McCune SA; Chung E; Leinwand LA; McKinsey TA
J Mol Cell Cardiol; 2011 Jul; 51(1):41-50. PubMed ID: 21539845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
